BOSTON, April 9, 2025 -- Solu Therapeutics, a biotechnology company pioneering therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, today announced the successful completion of a $41 million Series...
Arthur Klausner to be a featured speaker at CED Biotech Forum: Trends in Exit Strategies.
News | 06. 18. 2007
